Methylprednisolone - acute spinal cord injury, benefits or risks?

被引:0
|
作者
Tesiorowski, Maciej [1 ]
Potaczek, Tomasz [1 ]
Jasiewicz, Barbara [1 ]
Sapa, Jacek [2 ]
Zygmunt, Malgorzata [2 ]
机构
[1] Uniwersytetu Jagiellonskiego, Katedra & Klin Ortopedii & Rehabil Zakopanem, Coll Med, PL-30688 Krakow, Poland
[2] Uniwersytetu Jagiellonskiego, Zaklad Wstepnych Badan Farmakol, Katedry Farmakodynamiki, Coll Med, PL-30688 Krakow, Poland
关键词
methylprednisolone; acute spinal cord injury; inflammatio; neuroprotection; HIGH-DOSE METHYLPREDNISOLONE; EFFICACY; STEROIDS; NALOXONE;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Methylprednisolone is a synthetic glucocorticoid with a potent and long-acting anti-inflammatory, antiallergic and immunosuppressant. Its mechanism of action of methylprednisolone is the result of many cellular changes. Methylprednisolone is used in many diseases, such as rheumatic diseases, autoimmune diseases, allergic, anaphylactic shock, asthma. Methylprednisolone was also used in patients with spinal cord injury, in order to minimize neurological damage. While in the above mentioned fields of medicine is undeniable role of methylprednisolone, whereas its use in the treatment of traumatic spinal cord injury within the last few years raises a lot of controversy, and in most cases, the side effects of its use outweigh the potential benefits.
引用
收藏
页码:601 / 609
页数:9
相关论文
共 50 条
  • [41] Methylprednisolone intrathecal injections suppress neuronal apoptosis following acute spinal cord injury
    Song, Xinghua
    Zhang, Jianjun
    Ding, Liwen
    Cao, Li
    Xu, Xiaoxiong
    Wen, Hao
    NEURAL REGENERATION RESEARCH, 2011, 6 (17) : 1306 - 1312
  • [42] Should high-dose methylprednisolone be administered in the treatment of acute spinal cord injury?
    Domino, Karen B.
    JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY, 2008, 20 (02) : 136 - 136
  • [43] A RANDOMIZED, CONTROLLED TRIAL OF METHYLPREDNISOLONE OR NALOXONE IN THE TREATMENT OF ACUTE SPINAL-CORD INJURY
    SENEGOR, M
    NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (17): : 1208 - 1208
  • [44] Combined treatment with Minocycline and methylprednisolone in acute traumatic spinal cord Injury: A pilot study
    Meshkini, Ali
    Ohadi, Mohammad Amin Dabbagh
    Mirghaderi, Peyman
    Mirzaei, Farhad
    Rafiei, Ebrahim
    Allahyari, Nima
    Namvar, Mohamad
    Iranmehr, Arad
    INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT, 2024, 36
  • [45] Methylprednisolone inhibits Nogo-A protein expression after acute spinal cord injury
    Zhaozong Fu
    Hai Lu
    Jianming Jiang
    Hui Jiang
    Zhaofei Zhang
    Neural Regeneration Research, 2013, 8 (05) : 404 - 409
  • [47] Methylprednisolone inhibits Nogo-A protein expression after acute spinal cord injury
    Fu, Zhaozong
    Lu, Hai
    Jiang, Jianming
    Jiang, Hui
    Zhang, Zhaofei
    NEURAL REGENERATION RESEARCH, 2013, 8 (05) : 404 - 409
  • [48] Efficacy and Safety of Methylprednisolone Sodium Succinate in Acute Spinal Cord Injury: A Systematic Review
    Fehlings, Michael G.
    Wilson, Jefferson R.
    Harrop, James S.
    Kwon, Brian K.
    Tetreault, Lindsay A.
    Arnold, Paul M.
    Singh, Jeffrey M.
    Hawryluk, Gregory
    Dettori, Joseph R.
    GLOBAL SPINE JOURNAL, 2017, 7 : 116S - 137S
  • [50] The Impact of Guidelines on Clinical Practice: Survey of the Use of Methylprednisolone for Acute Spinal Cord Injury
    Brooks, Nathaniel P.
    Potts, Eric
    O'Toole, John
    NEUROSURGERY, 2016, 79 (03) : E516 - E520